Literature DB >> 18763039

The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study.

Susan Matulevicius1, Anand Rohatgi, Amit Khera, Sandeep R Das, Andrew Owens, Colby R Ayers, Carlos H Timaran, Eric B Rosero, Mark H Drazner, Ronald M Peshock, James A de Lemos.   

Abstract

BACKGROUND: Caspase-3, an apoptosis protease, is expressed in atherosclerotic plaques. We examined the relationship between plasma caspase-3 levels, aortic compliance, and atherosclerosis.
METHODS: Caspase-3 was measured in 3,221 subjects from the Dallas Heart Study. Electron beam computed tomography measures of coronary calcium (CAC) (n = 2,404) and magnetic resonance imaging (MRI) measures of abdominal aortic wall thickness (AWT) (n = 2,208) and aortic compliance (AC) (n = 2,328) were obtained. Multivariate analyses were performed, adjusting for age, sex, ethnicity, body mass index (BMI), traditional cardiovascular risk factors, and cardiac medications.
RESULTS: In univariable analysis, caspase-3 associated with CAC (P < 0.0001), AWT (P = 0.002), and AC (P < 0.0001). After multivariable adjustment, 4th quartile caspase-3 (compared to 1st quartile) was significantly associated with CAC (P = 0.004), AWT (P = 0.02), and AC (P < 0.0001) with similar findings for caspase-3 as a continuous variable.
CONCLUSIONS: Caspase-3 independently associates with CAC, AWT, and AC, suggesting a link between apoptosis and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763039     DOI: 10.1007/s10495-008-0254-1

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  4 in total

1.  Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study.

Authors:  Leticia Castillo; Anand Rohatgi; Colby R Ayers; Andrew W Owens; Sandeep R Das; Amit Khera; Darren K McGuire; James A de Lemos
Journal:  J Interferon Cytokine Res       Date:  2010-05       Impact factor: 2.607

2.  Sarcopenia: clinical evaluation, biological markers and other evaluation tools.

Authors:  M Pahor; T Manini; M Cesari
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

3.  The Protective Effect of Bosentan against Atherosclerosis in Apolipoprotein E-Deficient Mice Is Mediated by miRNA-21.

Authors:  Xiaona Xu; Zhiqiang Zhao; Guangping Li
Journal:  Biomed Res Int       Date:  2019-12-05       Impact factor: 3.411

4.  Hyperglycaemia-associated Caspase-3 predicts diabetes and coronary artery disease events.

Authors:  Jiangming Sun; Pratibha Singh; Johan Österlund; Marju Orho-Melander; Olle Melander; Gunnar Engström; Andreas Edsfeldt
Journal:  J Intern Med       Date:  2021-07-26       Impact factor: 8.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.